Literature DB >> 8605117

Characterization of regions of chromosomes 12 and 16 involved in nephroblastoma tumorigenesis.

E Austruy1, S Candon, I Henry, G Gyapay, M F Tournade, M Mannens, D Callen, C Junien, C Jeanpierre.   

Abstract

There are at least three loci involved in Wilms' tumor (WT) tumorigenesis: WT1 in 11p13, WT2 in 11p15.5, and WT3, as yet unmapped. A compilation of cytogenetic data published for 107 WT revealed that deletion of chromosome 16 and duplication of chromosome 12 occur as frequently as the well-documented 11p deletions. Allelic imbalance for chromosomes 16 and 12 was investigated in a series of 28 WT. By use of a large panel of restriction fragment length polymorphisms and (CA)n probes, we demonstrated loss of heterozygosity (LOH) for 16q in seven (25%) of the tumors. The whole length of 16q was involved in six of the tumors. Moreover, consistent with a previous report of 16q13 LOH in a sporadic WT and a constitutional breakpoint with a Beckwith-Wiedemann patient, we map a region of particular interest to between D16S308 and D16S320. The assumption that 16q LOH may be an early event was based on: 1) the detection of 16q LOH in one case of nephroblastomatosis; 2) the presence of a complete (clonal) 16q LOH in a tumor with partial (mosaic) 11p LOH; and 3) 16q LOH as the sole abnormality in one WT. By quantification of chromosome 12 allelic imbalance, we detected duplication in 18% of the total series and in 25% of the sporadic unilateral cases. The common region extended from the centromere to D12S7 in 12q21.1-q23. We also suggest that the various pathogenetically important loci are not equally involved in the different forms of WT and that their sequential involvement may differ.

Entities:  

Mesh:

Year:  1995        PMID: 8605117     DOI: 10.1002/gcc.2870140407

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  10 in total

1.  Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.

Authors:  A K Charles; K W Brown; P J Berry
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

2.  A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1.

Authors:  R W Johnstone; R H See; S F Sells; J Wang; S Muthukkumar; C Englert; D A Haber; J D Licht; S P Sugrue; T Roberts; V M Rangnekar; Y Shi
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

3.  Wilms' tumor in patients with 9q22.3 microdeletion syndrome suggests a role for PTCH1 in nephroblastomas.

Authors:  Bertrand Isidor; Franck Bourdeaut; Delfine Lafon; Ghislaine Plessis; Elodie Lacaze; Caroline Kannengiesser; Sylvie Rossignol; Olivier Pichon; Annaig Briand; Dominique Martin-Coignard; Maria Piccione; Albert David; Olivier Delattre; Cécile Jeanpierre; Nicolas Sévenet; Cédric Le Caignec
Journal:  Eur J Hum Genet       Date:  2012-11-21       Impact factor: 4.246

4.  Loss of the retinoblastoma protein-related p130 protein in small cell lung carcinoma.

Authors:  K Helin; K Holm; A Niebuhr; H Eiberg; N Tommerup; S Hougaard; H S Poulsen; M Spang-Thomsen; P Norgaard
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

5.  Deletions of 16q in Wilms tumors localize to blastemal-anaplastic cells and are associated with reduced expression of the IRXB renal tubulogenesis gene cluster.

Authors:  Linda Holmquist Mengelbier; Jenny Karlsson; David Lindgren; Ingrid Øra; Margareth Isaksson; Ildiko Frigyesi; Attila Frigyesi; Johannes Bras; Bengt Sandstedt; David Gisselsson
Journal:  Am J Pathol       Date:  2010-09-16       Impact factor: 4.307

6.  Activation of the human homologue of the Drosophila sina gene in apoptosis and tumor suppression.

Authors:  M Nemani; G Linares-Cruz; H Bruzzoni-Giovanelli; J P Roperch; M Tuynder; L Bougueleret; D Cherif; M Medhioub; P Pasturaud; V Alvaro; H der Sarkissan; L Cazes; D Le Paslier; I Le Gall; D Israeli; J Dausset; F Sigaux; I Chumakov; M Oren; F Calvo; R B Amson; D Cohen; A Telerman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

7.  Loss of heterozygosity at 7p in Wilms' tumour development.

Authors:  R M Powlesland; A K Charles; K T Malik; P A Reynolds; S Pires; M Boavida; K W Brown
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

Review 8.  Genetic variation frequencies in Wilms' tumor: A meta-analysis and systematic review.

Authors:  Changkai Deng; Rong Dai; Xuliang Li; Feng Liu
Journal:  Cancer Sci       Date:  2016-03-18       Impact factor: 6.716

Review 9.  Prostate apoptosis response-4 and tumor suppression: it's not just about apoptosis anymore.

Authors:  Anees Rahman Cheratta; Faisal Thayyullathil; Siraj Pallichankandy; Karthikeyan Subburayan; Ameer Alakkal; Sehamuddin Galadari
Journal:  Cell Death Dis       Date:  2021-01-07       Impact factor: 8.469

10.  Loss of heterozygosity on chromosome 16 in sporadic Wilms' tumour.

Authors:  R G Grundy; J Pritchard; P Scambler; J K Cowell
Journal:  Br J Cancer       Date:  1998-11       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.